Eliquis refers to apixaban, a direct factor Xa inhibitor commonly prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as to prevent… Read more
Eliquis refers to apixaban, a direct factor Xa inhibitor commonly prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as to prevent deep vein thrombosis and pulmonary embolism following hip or knee replacement surgery. This category provides access to essential analytical materials, including reference standards of the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds like Apixaban-13C, d3. These high-quality materials are critical for laboratories performing impurity profiling, method validation, and quantitative bioanalysis. By utilizing these stable isotope-labelled standards and impurity reference materials, researchers can ensure accurate detection, identification, and quantification of target compounds throughout drug development, regulatory testing, and routine quality control processes to maintain rigorous pharmaceutical standards.